Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer.

Gobbini, Elisa; Swalduz, Aurélie; Levra, Matteo Giaj; Ortiz-Cuaran, Sandra; Toffart, Anne-Claire; Pérol, Maurice; Moro-Sibilot, Denis; Saintigny, Pierre

Gobbini, Elisa; Swalduz, Aurélie; Levra, Matteo Giaj; Ortiz-Cuaran, Sandra; Toffart, Anne-Claire; Pérol, Maurice; Moro-Sibilot, Denis; Saintigny, Pierre.

Afiliação

Gobbini E; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France.
Swalduz A; Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France.
Levra MG; Department of Medical Oncology, Centre Léon Bérard, Lyon 69373, France.
Ortiz-Cuaran S; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France.
Toffart AC; Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France.
Pérol M; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France.
Moro-Sibilot D; Department of Medical Oncology, Centre Léon Bérard, Lyon 69373, France.
Saintigny P; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France.

Cancers (Basel) ; 12(11)2020 Oct 24.

Article em En | MEDLINE | ID: mdl-33114393

Palavras-chave

biomarker; circulating tumor DNA; liquid biopsy; lung cancer; next-generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google